MJNA - Medical Marijuana, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0490
-0.0010 (-2.00%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close0.0500
Open0.0450
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0450 - 0.0500
52 Week Range0.0400 - 0.1200
Volume5,076,309
Avg. Volume7,570,119
Market Cap226.106M
Beta (3Y Monthly)-2.10
PE Ratio (TTM)N/A
EPS (TTM)-0.0160
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Path to marijuana legalization in the U.S.
    Yahoo Finance Video2 months ago

    Path to marijuana legalization in the U.S.

    The FDA is holding a hearing today to look into the science and safety of products containing cannabis and CDB. Stuart Titus, Medical Marijuana Inc CEO, is attending the hearing, and joins Yahoo Finance with his take.

  • PR Newswire3 days ago

    Medical Marijuana, Inc. Subsidiary Kannaway® Grows International Leadership Team With Janne Heimonen as Managing Director of European Division

    SAN DIEGO, July 17, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that that its subsidiary Kannaway® has appointed Janne Heimonen as Managing Director of its burgeoning European Division. Kannaway® currently ships its products to many countries within the EU. The company is working to expand access to CBD and hemp throughout Europe and has grown to a nearly $40 million revenue run rate since its official launch in 2018.

  • PR Newswire9 days ago

    Medical Marijuana, Inc. Subsidiary Kannaway® Announces Updated Branding Strategy and Website to Expand Consumer Reach

    SAN DIEGO, July 11, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) ("the Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that its subsidiary Kannaway® has launched a completely redesigned website and the rebranding of its globally recognized hemp-derived cannabidiol (CBD) products. Through its newly designed consumer-driven website, the Company hopes that consumers will find it easier to navigate for access to the products and CBD education that fits their unique lifestyles.

  • PR Newswire11 days ago

    Medical Marijuana, Inc. and Subsidiaries Kannaway® and HempMeds® Announce June 2019 as the Largest Sales Bookings Month in Company History

    - Medical Marijuana, Inc. completed the first-ever high-level stability study on a cannabidiol (CBD) hemp oil product - Subsidiary Kannaway® began pre-marketing initiatives in Japan ahead of significant ...

  • PR Newswire18 days ago

    Medical Marijuana, Inc. Subsidiary Kannaway® Announces European Industrial Hemp Association Membership

    SAN DIEGO, July 2, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has become a member of the European Industrial Hemp Association (EIHA) and will participate in the organization's operational and legislative activities.

  • PR Newswire23 days ago

    Medical Marijuana, Inc. Issues Letter to Shareholders

    SAN DIEGO, June 27, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that it has issued a letter to its shareholders, providing commentary on the Company's recent financial and operational results and upcoming objectives. Overview of the Company's "One Plant | Three Initiatives" approach to capitalize on the growing industrial hemp and CBD industries by being a global house of brands, leader in research and development of cannabinoid-based therapeutics, and worldwide supplier of high-quality CBD raw materials. Commentary on the Company's financial progress and recent financial results, which included record gross sales, increased gross profit, decreases in operating expenses as a percentage of sales, and a non-GAAP financial analysis including adjusted EBITDA for the most recent quarter.

  • PR Newswire24 days ago

    Medical Marijuana, Inc. Major Investment Company AXIM® Biotechnologies, Inc.'s Cannabinoid Oral Care Products Registered For Use In Clinical Trials Through Australian Healthcare Partner

    NEW YORK , June 26, 2019 /PRNewswire/ -- Medical Marijuana, Inc.  (OTC: MJNA ) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's ...

  • Dixie Botanicals®, Subsidiary of Medical Marijuana, Inc., Announces Partnership with Surface Products Corp. To Sell Fitness-Focused CBD-Infused Sunscreen
    PR Newswire29 days ago

    Dixie Botanicals®, Subsidiary of Medical Marijuana, Inc., Announces Partnership with Surface Products Corp. To Sell Fitness-Focused CBD-Infused Sunscreen

    SAN DIEGO, June 21, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Dixie Botanicals® has partnered with Surface Products Corp. to sell a fitness-focused hemp-derived CBD sunscreen for active consumers.

  • PR Newswirelast month

    Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Announces Third Series of Cannabinoid Medicine Courses in São Paulo

    - The company's Brazilian subsidiary is launching its third series of courses to teach doctors about cannabinoids, the endocannabinoid system and potential therapeutic uses of cannabidiol (CBD) in Brazil ...

  • PR Newswirelast month

    Medical Marijuana, Inc. Major Investment Company AXIM® Biotechnologies, Inc. Moves Forward on Oral Healthcare Line With Cannabinoid Product Supply Agreement

    SAN DIEGO , June 13, 2019 /PRNewswire/ --  Medical Marijuana, Inc. (OTC:MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever ...

  • Medical Marijuana, Inc. Announces Completion of the First-Ever High-Level Stability Study on a CBD Hemp Oil Product
    PR Newswirelast month

    Medical Marijuana, Inc. Announces Completion of the First-Ever High-Level Stability Study on a CBD Hemp Oil Product

    SAN DIEGO, June 12,  2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company has reached a major milestone for long-term stability testing on its flagship THC-free cannabidiol (CBD) oil product Real Scientific Hemp Oil-X™ (RSHO-XTM). "We're excited to offer consumers and retail partners the transparency and security of knowing that our products are reliable and stable throughout several climatic conditions and through transportation," said Medical Marijuana, Inc. CEO Dr. Stuart Titus. This helps the company ensure to its customers and retailers that the integrity of the product will not be compromised while in transportation or while being stored for future use," said Medical Marijuana, Inc. Vice President of Project Analysis and R&D, Dr. Levan Darjania.

  • ACCESSWIRElast month

    Medical Marijuana, Inc. joins The Stock Day Podcast to Discuss Major Accomplishments for 2019

    PHOENIX, AZ / ACCESSWIRE / June 10, 2019 / The Stock Day Podcast welcomed Medical Marijuana, Inc. (OTC PINK: MJNA) ("the Company"), a cannabis company with three distinct business units in the non-psychoactive cannabinoid space. President and CEO, Dr. Stuart Titus, joined Stock Day host Everett Jolly. Jolly began the interview by asking about the Company's recent FDA hearing.

  • Medical Marijuana, Inc. Subsidiary HempMeds® Adds New CBD-Infused Products to Personal Care Line
    PR Newswirelast month

    Medical Marijuana, Inc. Subsidiary HempMeds® Adds New CBD-Infused Products to Personal Care Line

    Research firm Jeffries estimates that the CBD beauty category could reach $25 billion globally and will amass 15 percent of the total skin care market within the next decade. "We have a long history of being a pioneer in the CBD industry and want to continue to be recognized as a leader in industry trends with these new products," said HempMeds® President Todd Morrow. HempMeds® Personal Care Line initially launched in April 2019 on International Women's Day and due to the positive response the company received about these products and feedback from customers who were looking for more topical options, HempMeds® made the strategic decision to add a Soothing Body Balm, a revitalized version of HempMeds® Active Relief Roll-On, and an Essential Body Oil.

  • PR Newswire2 months ago

    Medical Marijuana, Inc. Announces International Coverage at FDA Public Hearing on Cannabis and CBD Products

    SAN DIEGO, June 3, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that Dr. Stuart Titus, the Company's Chief Executive Officer, was featured in several national and international news publications about his speaking engagement at the U.S. Food and Drug Administration (FDA) Hearing on cannabis and cannabidiol (CBD) on Friday, May 31, 2019. Just last year, Medical Marijuana, Inc. saw a year-over-year revenue increase of more than 125% over 2017. Also, the Brightfield Group stated in its 2018 Annual Report that the CBD market is expected to grow by nearly 40 times within the next four years, outpacing the rest of the cannabis market, including Tetrahydrocannabinol (THC) marijuana products, to reach $22 billion by 2022.

  • Marijuana CEO: 'Many of us are cannabinoid deficient'
    Yahoo Finance2 months ago

    Marijuana CEO: 'Many of us are cannabinoid deficient'

    Medical Marijuana Inc (MJNA) CEO Stuart Titus is optimistic about the effects that cannabis-derived products have on humans.

  • Medical Marijuana, Inc. Subsidiary HempMeds® Launches New Everyday Wellness Functional CBD Solutions Product Line
    PR Newswire2 months ago

    Medical Marijuana, Inc. Subsidiary HempMeds® Launches New Everyday Wellness Functional CBD Solutions Product Line

    SAN DIEGO , May 30, 2019 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever ...

  • PR Newswire2 months ago

    Medical Marijuana, Inc. CEO to Present on CBD Safety at Sixth Annual New York Cannabis World Congress; Subsidiary HempMeds® to Exhibit New CBD Products

    SAN DIEGO, May 29, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company's CEO Dr. Stuart Titus will speak on medical cannabis and cannabidiol (CBD) safety at the Sixth Annual Cannabis World Congress & Wellness Expo in New York on May 30-June 1. The Company's subsidiary HempMeds® will be exhibiting at the conference and will be launching a new CBD product line.

  • PR Newswire2 months ago

    Medical Marijuana, Inc. Subsidiary Kannaway® Announces First-Ever Authorization in Bulgaria to Sell Hemp-Derived CBD Products

    SAN DIEGO, May 28, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that it has received the first-ever authorization in Bulgaria to sell hemp-derived cannabidiol (CBD) products. "As the EU continues to navigate its stance on CBD, we are proud to continue paving the way for the acceptance of CBD in Bulgaria just as we have in many other countries around the world," said Kannaway® CEO Blake Schroeder. This authorization certifies that Kannaway®'s imported goods are normally and freely sold in the certifying country's open markets and are approved for export.

  • PR Newswire2 months ago

    Medical Marijuana, Inc. Portfolio Company Kannalife, Inc. Publishes New Research on CBD and Chemotherapy-Induced Peripheral Neuropathy

    SAN DIEGO , May 23, 2019 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever ...

  • Medical Marijuana, Inc. Reports Over $20.2M in Revenue in Q1 2019, Up 92% Year-Over-Year in Financial Results
    PR Newswire2 months ago

    Medical Marijuana, Inc. Reports Over $20.2M in Revenue in Q1 2019, Up 92% Year-Over-Year in Financial Results

    SAN DIEGO , May 22, 2019 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , announced today its financial results for the quarter ...

  • PR Newswire2 months ago

    Medical Marijuana, Inc. CEO Chosen to Present Oral Comments at FDA's Public Hearing on Products Containing Cannabis and Cannabis-Derived Compounds

    SAN DIEGO, May 21, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, announced today that the Company's CEO, Dr. Stuart Titus, has been chosen as one of 65 speakers to present oral comments at the U.S. Food & Drug Administration (FDA)'s upcoming public hearing discussing scientific data and information about products containing cannabis-derived compounds. Titus was chosen from nearly 400 applicants and will give his oral comments between 8:00 a.m. and 10:30 a.m. on Friday, May 31, 2019. "I'm honored to be given this opportunity to speak on a national stage about why cannabidiol (CBD) as derived from industrial hemp and in its botanical form, should be allowed as a dietary supplement and food ingredient.

  • Market Exclusive2 months ago

    Cannabis Stock News Daily Roundup May 15

    GrowGeneration (OTCQX: GRWG) has purchased the assets of GreenLife Garden Supply, including two locations in Maine and one in New Hampshire. The acquisition brings the company's total retail and warehouse locations to five that services the growing number of commercial cultivators in the New England market. Target Group (OTCQB: CBDY) subsidiary Canary Rx has submitted a site […]The post Cannabis Stock News Daily Roundup May 15 appeared first on Market Exclusive.

  • Medical Marijuana, Inc. Subsidiary Dixie Botanicals® Launches New Natural Orange-Flavored CBD Tincture
    PR Newswire2 months ago

    Medical Marijuana, Inc. Subsidiary Dixie Botanicals® Launches New Natural Orange-Flavored CBD Tincture

    SAN DIEGO , May 15, 2019 /PRNewswire/ --  Medical Marijuana, Inc .  (OTC: MJNA), the first publicly traded cannabis company in the United States , announced today that its subsidiary  Dixie Botanicals® ...

  • PR Newswire2 months ago

    Medical Marijuana, Inc. Major Investment Company Axim® Biotechnologies Files New U.S. Provisional Patent for Cannabis Gum as a Treatment for Migraine Symptoms

    NEW YORK , May 14, 2019 /PRNewswire/ --  Medical Marijuana, Inc.  (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , today announced that the Company's major investment ...

  • PR Newswire2 months ago

    Medical Marijuana, Inc. Announces April 2019 as the Largest Sales Bookings Month in Company History

    SAN DIEGO , May 9, 2019 /PRNewswire/ --  Medical Marijuana, Inc.  (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , today announced that the company had its the largest-ever ...